Transcription of Colorectal Cancer Screening and Surveillance - Cigna
{{id}} {{{paragraph}}}
Page 1 of 42 Medical Coverage Policy: 0148 Medical Coverage Policy Effective Date ..10/15/2021 Next Review Date ..10/15/2022 Coverage Policy Number .. 0148 Colorectal Cancer Screening and Surveillance Table of Contents Overview .. 1 Coverage Policy .. 1 General Background .. 2 Medicare Coverage Determinations .. 32 Coding/Billing Information .. 32 References .. 34 Related Coverage Resources Genetic Testing for hereditary Cancer Susceptibility Syndromes Preventive Care Services Tumor Profiling, Gene Expression Assays, and Molecular Diagnostic Testing for Hematology/Oncology Indications INSTRUCTIONS FOR USE The following Coverage Policy applies to health benefit plans administered by Cigna Companies.
A confirmed or suspected hereditary colorectal cancer syndrome, such as familial adenomatous polyposis (FAP) or Lynch syndrome (hereditary non-polyposis colon cancer or HNPCC) A personal history of getting radiation to the abdomen or pelvic area to treat a prior cancer Increased or high risk for developing CRC includes:
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}
CANCER SCREENING GUIDELINES, Colorectal cancer, Hereditary nonpolyposis colorectal cancer, Cancer, Legal and Regulatory Services Branch, Hereditary non-polyposis colorectal cancer, Colorectal Cancer Early Detection, Diagnosis, and Staging, Hereditary colorectal cancer, Polyposis, Hereditary Non, Colorectal Cancer Causes, Risk Factors, and Prevention, Colorectal, Hereditary, Blueprint, American Board of Internal